IP Library Patent Application 14648940
Patent Application
App. No. 14/648,940

COSMETIC USE OF A CAROB SEED EXTRACT AS A SLIMMING ACTIVE AGENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/648,940
Filed
Jun 2, 2015
Art Unit
1655
USPC
424/725
Abstract

Cosmetic methods for obtaining a slimming effect are disclosed. The methods include providing a composition containing a carob ( Ceratonia siliqua L.) seed extract as a slimming agent and a physiologically acceptable medium, and topically applying the composition on at least a portion of the body or face. The topical application of the composition includes the application of an effective amount of the composition that increases the expression of aquaglyceroporins, promotes lipolysis, and/or reduces localized excess body fat.

Claims (13)

1 . A cosmetic method for obtaining a slimming effect comprising:

providing a composition containing a carob germ extract ( Ceratonia siliqua L.) as a slimming active agent, and a physiologically acceptable medium; and

topically applying the composition on at least a portion of the skin of the body or face.

2 . The method according to claim 1 , wherein the carob germ extract is diluted in one or more physiologically acceptable solvents selected from the group consisting of water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, and combinations thereof.

3 . The method according to claim 1 , wherein the carob germ extract contains between 1.5 and 3.5 g/l of peptide compounds.

4 . The method according to claim 1 , wherein the carob germ extract is a peptide extract wherein the peptide compounds have a molecular weight below 5 kDa.

5 . The method according to claim 1 , wherein topically applying comprises the application of an effective amount of the composition that increases the expression of aquaglyceroporins.

6 . The method according to claim 1 , wherein topically applying comprises the application of an effective amount of the composition that promotes lipolysis, the elimination of lipids and the export of glycerol from the adipocytes.

7 . The method according to claim 1 , wherein topically applying comprises the application of an effective amount of the composition that reduces localized excess body fat.

8 . The method according to claim 1 , wherein the carob germ extract is present in a concentration of between 0.0001% and 20% of the total weight of the composition.

9 . The method according to claim 1 , wherein the composition further comprises at least one additional active agent selected from the group consisting of vitamin A, retinoic acid, retinol, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin E, vitamin F, vitamin H, vitamin K, vitamin PP, coenzyme Q10, metalloproteinase inhibitors, amino acids, carnitine, carnosine, taurine, natural or synthetic peptides, plant-based peptides, yeast extracts, Artemia Salina extracts, phytosterols of synthetic or natural origin, salicylic acid, oligosaccharides, polysaccharides, amino sugars, polyphenols, flavonoids, lipids, phospholipids, cyclic AMP and derivatives thereof, adenylate cyclase enzyme activating agents, phosphodiesterase enzyme inhibiting agents, thein, theophylline, theobromine, forskoline, esculin, ACE inhibitors, dioscorea extract, guarana extract, ivy extract, rockweed extract, algae extract such as Palmata Palmaria , hydrolyzed Prunella vulgaris extract or elderberry extract.

10 . The method according to claim 5 , wherein the aquaglyceroporin is aquaglyceroporin 7.

11 . The method according to claim 8 , wherein the carob germ extract is present in a concentration of between 0.05% and 5% of the total weight of the composition.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2015
From: BOTTO, JEAN-MARIE; DOMLOGE, NOUHA; PORTOLAN, FREDERIQUE
To: ISP INVESTMENTS INC.
Reel/Frame 035764/0168 →